Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
4.330
+0.050 (1.17%)
At close: Dec 5, 2025, 4:00 PM EST
4.380
+0.050 (1.15%)
After-hours: Dec 5, 2025, 7:48 PM EST
Vistagen Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | -62.24 | -51.42 | -29.36 | -59.25 | -47.76 | -17.93 | |
| Depreciation & Amortization | 0.68 | 0.64 | 0.57 | 0.53 | 0.71 | 0.48 | |
| Other Amortization | - | - | - | - | 0.23 | - | |
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | - | - | |
| Loss (Gain) From Sale of Investments | -0.5 | -0.39 | - | - | - | - | |
| Stock-Based Compensation | 4.05 | 4.32 | 2.18 | 3.34 | 3.48 | 2.31 | |
| Other Operating Activities | 0 | - | - | 3.64 | - | - | |
| Change in Accounts Payable | 5.71 | 5.68 | 0.52 | -0.93 | 1.69 | 0.05 | |
| Change in Unearned Revenue | -0.65 | -0.41 | 0.52 | 0.21 | -1 | 3.67 | |
| Change in Other Net Operating Assets | -0.01 | -0.51 | -0.25 | 2.76 | -2.6 | -0.64 | |
| Operating Cash Flow | -52.95 | -42.1 | -25.81 | -49.72 | -45.26 | -12.07 | |
| Capital Expenditures | -0.21 | -0.19 | -0.06 | -0.21 | -0.2 | -0.28 | |
| Cash Acquisitions | - | - | - | -0.53 | - | - | |
| Investment in Securities | -0.56 | -12.96 | - | - | - | - | |
| Investing Cash Flow | -0.78 | -13.15 | -0.06 | -0.74 | -0.2 | -0.28 | |
| Short-Term Debt Issued | - | - | - | - | - | 0.22 | |
| Total Debt Issued | 1.02 | - | - | - | - | 0.22 | |
| Short-Term Debt Repaid | - | - | -0.99 | -1.03 | - | -0.6 | |
| Long-Term Debt Repaid | - | - | - | - | -0 | -0 | |
| Total Debt Repaid | -0.36 | - | -0.99 | -1.03 | -0 | -0.61 | |
| Net Debt Issued (Repaid) | 0.66 | - | -0.99 | -1.03 | -0 | -0.38 | |
| Issuance of Common Stock | 31.61 | 3.21 | 129.39 | 0.17 | 10.49 | 114.48 | |
| Other Financing Activities | - | - | - | -0.17 | - | - | |
| Financing Cash Flow | 32.26 | 3.21 | 128.4 | -1.04 | 10.48 | 114.1 | |
| Net Cash Flow | -21.46 | -52.04 | 102.53 | -51.5 | -34.97 | 101.75 | |
| Free Cash Flow | -53.16 | -42.29 | -25.87 | -49.93 | -45.46 | -12.35 | |
| Free Cash Flow Margin | -7373.09% | -8701.24% | -2431.77% | - | -4099.28% | -1133.45% | |
| Free Cash Flow Per Share | -1.64 | -1.37 | -1.34 | -7.17 | -6.89 | -4.30 | |
| Cash Interest Paid | 0.02 | - | - | - | - | 0.01 | |
| Cash Income Tax Paid | - | - | - | - | - | 0 | |
| Levered Free Cash Flow | -30.83 | -23.27 | -18 | -32.74 | -25.98 | -8.07 | |
| Unlevered Free Cash Flow | -30.83 | -23.27 | -18 | -32.74 | -26.21 | -8.06 | |
| Change in Working Capital | 5.05 | 4.76 | 0.79 | 2.03 | -1.92 | 3.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.